Abstracts accepted for presentation provide updates on ongoing EVEREST-2 clinical study and describe approaches to boost ...
Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules ...
Charlie Smith. Poster exhibit. Case of Fetal Immature Trauma. The Southern Radiological Conference, Marriott's Grand Hotel, Resort and Spa, Point Clear, Alabama, January 25-27, 2013. Charlie Smith.
Late-breaking poster presentation to highlight new biopsy data demonstrating elimination and inactivation of cccDNA from the ongoing Phase 1 ELIMINATE-B trial in chronic hepatitis B -DURHAM, ...
OBI Pharma is a clinical-stage global oncology company established in 2002 and headquartered in Taiwan. Together with its subsidiary OBI Pharma USA, Inc., the company is dedicated to developing ...
(Korro) (Nasdaq: KRRO), a biopharmaceutical company developing a new class of genetic medicines based on editing RNA for rare and highly prevalent diseases, today announced oral and poster ...
The Association of American Feed Control Officials (AAFCO) is hosting its first Graduate Student Poster Presentation Contest ...
All Environmental Studies majors participate in public poster presentations as part of the thesis process. A poster session is organized for Wednesday in the last week of the fall and winter semesters ...
Moleculin Biotech, Inc., (Nasdaq: MBRX) ('Moleculin” or the 'Company”), today announced that an abstract highlighting data on its lead drug candidate, annamycin, has been accepted for poster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results